Cybrexa Therapeutics Completes Successful Pre-IND Meeting With FDA for CBX-12 (alphalex™-exatecan), a Novel Treatment for Solid Tumors

Mike Viscel
Increasing Engagement

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Laura Blair
Medication Adherence

Anil Bhaskar
Unified Customer Experience

Frank X. Powers
Healthcare Challenger Brands

Paul Theisen
Patient Acquisition

David Linetsky
Patient Activation

Thomas Shea
Programmatic Marketing

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement